Galidesivir (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Galidesivir" in English language version.

refsWebsite

Global rank English rank

4^th place

4^th place

2^nd place

2^nd place

18^th place

17^th place

1globenewswire.com

2,614^th place

1,549^th place

1clinicaltrials.gov

5,225^th place

4,062^nd place

54^th place

48^th place

1web.archive.org

1^st place

1^st place

1clinicaltrialsarena.com

low place

low place

clinicaltrials.gov

Clinical trial number NCT03891420 for "A Study to Evaluate the Safety, Pharmacokinetics and Antiviral Effects of Galidesivir in Yellow Fever or COVID-19" at ClinicalTrials.gov

clinicaltrialsarena.com

Duddu P (19 February 2020). "Coronavirus outbreak: Vaccines/drugs in the pipeline for Covid-19". clinicaltrialsarena.com. Archived from the original on 19 February 2020. Retrieved 19 February 2020.

doi.org

Warren TK, Wells J, Panchal RG, Stuthman KS, Garza NL, Van Tongeren SA, et al. (April 2014). "Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430". Nature. 508 (7496): 402–405. Bibcode:2014Natur.508..402W. doi:10.1038/nature13027. PMC 7095208. PMID 24590073.
Kamat SS, Burgos ES, Raushel FM (October 2013). "Potent inhibition of the C-P lyase nucleosidase PhnI by Immucillin-A triphosphate". Biochemistry. 52 (42): 7366–7368. doi:10.1021/bi4013287. PMC 3838859. PMID 24111876.
Westover JB, Mathis A, Taylor R, Wandersee L, Bailey KW, Sefing EJ, et al. (August 2018). "Galidesivir limits Rift Valley fever virus infection and disease in Syrian golden hamsters". Antiviral Research. 156: 38–45. doi:10.1016/j.antiviral.2018.05.013. PMC 6035881. PMID 29864447.
Julander JG, Siddharthan V, Evans J, Taylor R, Tolbert K, Apuli C, et al. (January 2017). "Efficacy of the broad-spectrum antiviral compound BCX4430 against Zika virus in cell culture and in a mouse model". Antiviral Research. 137: 14–22. doi:10.1016/j.antiviral.2016.11.003. PMC 5215849. PMID 27838352.
Lim SY, Osuna CE, Best K, Taylor R, Chen E, Yoon G, et al. (June 2020). "A direct-acting antiviral drug abrogates viremia in Zika virus-infected rhesus macaques". Science Translational Medicine. 12 (547). doi:10.1126/scitranslmed.aau9135. PMC 7370316. PMID 32522808.

forbes.com

Rodgers P (8 April 2014). "BioWar Lab Helping To Develop Treatment For Ebola". Forbes Magazine.

globenewswire.com

BioCryst Pharmaceuticals, Inc. (June 10, 2020). "Galidesivir Stops Zika Viral Replication in Primate Model". GlobeNewswire News Room (Press release).

harvard.edu

ui.adsabs.harvard.edu

Warren TK, Wells J, Panchal RG, Stuthman KS, Garza NL, Van Tongeren SA, et al. (April 2014). "Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430". Nature. 508 (7496): 402–405. Bibcode:2014Natur.508..402W. doi:10.1038/nature13027. PMC 7095208. PMID 24590073.

nih.gov

ncbi.nlm.nih.gov

Warren TK, Wells J, Panchal RG, Stuthman KS, Garza NL, Van Tongeren SA, et al. (April 2014). "Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430". Nature. 508 (7496): 402–405. Bibcode:2014Natur.508..402W. doi:10.1038/nature13027. PMC 7095208. PMID 24590073.
Kamat SS, Burgos ES, Raushel FM (October 2013). "Potent inhibition of the C-P lyase nucleosidase PhnI by Immucillin-A triphosphate". Biochemistry. 52 (42): 7366–7368. doi:10.1021/bi4013287. PMC 3838859. PMID 24111876.
Westover JB, Mathis A, Taylor R, Wandersee L, Bailey KW, Sefing EJ, et al. (August 2018). "Galidesivir limits Rift Valley fever virus infection and disease in Syrian golden hamsters". Antiviral Research. 156: 38–45. doi:10.1016/j.antiviral.2018.05.013. PMC 6035881. PMID 29864447.
Julander JG, Siddharthan V, Evans J, Taylor R, Tolbert K, Apuli C, et al. (January 2017). "Efficacy of the broad-spectrum antiviral compound BCX4430 against Zika virus in cell culture and in a mouse model". Antiviral Research. 137: 14–22. doi:10.1016/j.antiviral.2016.11.003. PMC 5215849. PMID 27838352.
Lim SY, Osuna CE, Best K, Taylor R, Chen E, Yoon G, et al. (June 2020). "A direct-acting antiviral drug abrogates viremia in Zika virus-infected rhesus macaques". Science Translational Medicine. 12 (547). doi:10.1126/scitranslmed.aau9135. PMC 7370316. PMID 32522808.

pubmed.ncbi.nlm.nih.gov

Warren TK, Wells J, Panchal RG, Stuthman KS, Garza NL, Van Tongeren SA, et al. (April 2014). "Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430". Nature. 508 (7496): 402–405. Bibcode:2014Natur.508..402W. doi:10.1038/nature13027. PMC 7095208. PMID 24590073.
Kamat SS, Burgos ES, Raushel FM (October 2013). "Potent inhibition of the C-P lyase nucleosidase PhnI by Immucillin-A triphosphate". Biochemistry. 52 (42): 7366–7368. doi:10.1021/bi4013287. PMC 3838859. PMID 24111876.
Westover JB, Mathis A, Taylor R, Wandersee L, Bailey KW, Sefing EJ, et al. (August 2018). "Galidesivir limits Rift Valley fever virus infection and disease in Syrian golden hamsters". Antiviral Research. 156: 38–45. doi:10.1016/j.antiviral.2018.05.013. PMC 6035881. PMID 29864447.
Julander JG, Siddharthan V, Evans J, Taylor R, Tolbert K, Apuli C, et al. (January 2017). "Efficacy of the broad-spectrum antiviral compound BCX4430 against Zika virus in cell culture and in a mouse model". Antiviral Research. 137: 14–22. doi:10.1016/j.antiviral.2016.11.003. PMC 5215849. PMID 27838352.
Lim SY, Osuna CE, Best K, Taylor R, Chen E, Yoon G, et al. (June 2020). "A direct-acting antiviral drug abrogates viremia in Zika virus-infected rhesus macaques". Science Translational Medicine. 12 (547). doi:10.1126/scitranslmed.aau9135. PMC 7370316. PMID 32522808.

web.archive.org

Duddu P (19 February 2020). "Coronavirus outbreak: Vaccines/drugs in the pipeline for Covid-19". clinicaltrialsarena.com. Archived from the original on 19 February 2020. Retrieved 19 February 2020.